Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.300 | Therapeutic | group | CTD_human | The involvement of hypophyseal-gonadal and hypophyseal-adrenal axes in arsenic-mediated ovarian and uterine toxicity: modulation by hCG. | 20146381 | 2010 | ||||
|
0.200 | Biomarker | group | MGD | |||||||
|
0.010 | Biomarker | group | BEFREE | Measurement of plasma adrenocorticotropic hormone (ACTH) is key in the differential diagnosis of hypothalamic-pituitary-adrenal disorders. | 31570632 | 2019 | ||||
|
0.010 | GeneticVariation | group | BEFREE | SDHB mutations are linked to the familial paraganglioma syndrome type 4 (PGL4), which is associated with predominantly extra-adrenal disease and has high metastatic rates. | 27896548 | 2017 | ||||
|
0.010 | Biomarker | group | BEFREE | Finally, mutational analysis of CITED2 and PBX1 was performed in patients with primary adrenal disorders. | 18984668 | 2009 | ||||
|
0.010 | Biomarker | group | BEFREE | Finally, mutational analysis of CITED2 and PBX1 was performed in patients with primary adrenal disorders. | 18984668 | 2009 | ||||
|
0.010 | GeneticVariation | group | BEFREE | The aim of the present study is to examine whether the Gly146Ala variation in the gene for SF-1, that is known to impair SF-1 function and related to adrenal disorders, affects susceptibility to type 2 diabetes. | 16564598 | 2006 | ||||
|
0.010 | Biomarker | group | BEFREE | In order to investigate further autoantibody reactivity with TPO, we have studied the TPO binding characteristics of sera from patients with autoimmune thyroid disease (n = 20), autoimmune adrenal disease (Addison's disease; n = 8) and apparently healthy blood donors (n = 9) using recombinant TPO expressed with a series of truncations and internal deletions. | 10520899 | 1999 | ||||
|
0.010 | Biomarker | group | BEFREE | Adrenocorticotropin receptor and adrenal disorders. | 9167964 | 1997 |